Open AccessStructure of drug prescriptions in the treatment of community-acquired pneumonia in hospitals (during 2012)
Author(s) -
О. А. Yakovleva,
N. V. Scherbeniuk
Publication year - 2013
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xvii.1.65.2013.36
Subject(s) - pneumonia , community acquired pneumonia , medicine , medical prescription , drug , pharmacotherapy , intensive care medicine , nonsteroidal , pharmacology
A retrospective analysis of 760 in-patient’s medical cards was performed in order to study a real practice of using drugs, when treating community acquired pneumonia in hospitals of Vinnitsa. The results showed that the patients received on the average 10,18±0,13 drugs for the treatment of community-acquired pneumonia. All the 760 patients obtained antibacterial medicines for a systemic use, one patient received on the average 2,51±0,03 (1 to 7) of them. Nonsteroidal anti-inflammatory drugs, (38,0%), sulphocamphocaine (29,7%), biogenic stimulators (23,2%), vitamins (8,6%) were prescribed quite often. The findings suggest polypragmasia and may serve a basis for planning a set of measures to improve pharmacotherapy of community-acquired pneumonia.